Support for H.S.
November 29, 2015
Category: Uncategorized
Tags: Untagged

Anakinra May Safely, Effectively Treat Hidradenitis Suppurativa.


Medscape (11/24, Haelle) reports that research suggests that “the anti-inflammatory biologic drug anakinra can safely and effectively treat the skin disorder hidradenitis suppurativa (HS).”
Medscape points out that “anakinra is a recombinant interleukin 1 (IL-1) receptor antagonist that blocks the biological activity of naturally occurring IL-1, a major mediator of the inflammatory response.”
The findings were published online in JAMA Dermatology.